Ares (ARES) Insider Selling 128,837 Founder Shares via Morgan Stanley
Rhea-AI Filing Summary
Ares Management Corporation (ARES) Form 144 notice details a proposed sale of 128,837 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $22,555,493.59. The shares were acquired as founders shares on 05/01/2014 from the issuer and the filing lists the holder as the person for whose account the sale is to be made. The filing also lists numerous recent Rule 10b5-1 sales by TJ CAPITAL INVESTORS LLC between 08/20/2025 and 09/09/2025 with individual sale amounts and gross proceeds disclosed. The filer attests there is no undisclosed material adverse information and references a 10b5-1 trading plan where applicable.
Positive
- Transparency: The filing discloses the exact number of shares (128,837) and the aggregate market value ($22,555,493.59) for the proposed sale.
- Compliance with trading rules: Multiple prior sales are identified as 10b5-1 plan transactions, indicating use of an established trading plan and disclosure.
- Provenance disclosed: The securities were acquired as founders shares on 05/01/2014 from the issuer, which clarifies the nature of the holdings.
Negative
- Significant insider liquidity: The proposed sale and numerous recent 10b5-1 transactions disclose substantial insider-originated selling activity with multi‑million dollar proceeds.
- Potential market impact: The filing shows large daily sale amounts listed over several dates which could affect perceptions of insider confidence, though no operational context is provided.
Insights
TL;DR: Insider intends to sell a block of founder shares while multiple systematic 10b5-1 sales occurred recently.
The filing shows a proposed disposal of 128,837 founder shares valued at $22.56M executed through a broker on the NYSE, which is presented alongside a string of 10b5-1 sales by TJ CAPITAL INVESTORS LLC with disclosed amounts and gross proceeds. As a disclosure document, it provides transparency on insider liquidity and trading plan usage but does not supply operational or earnings information to change a valuation model.
TL;DR: Routine insider notification consistent with Rule 144 and 10b5-1 procedures; no governance violations disclosed.
The Form 144 reports sale logistics and provenance of the shares (founders shares acquired from the issuer on 05/01/2014) and includes the filer’s representation about absence of undisclosed material adverse information. The filing documents use of a broker and references to a 10b5-1 plan for prior sales, which aligns with standard compliance practices for planned insider dispositions.